Product Images Gabapentin

This text appears to be the description of a medication called Gabapentin Oral Solution, manufactured by Camber Pharmaceuticals. The solution contains 250 mg of gabapentin per 5 mL. It is recommended to store the solution refrigerated between 2°C to 8°C (36°F to 46°F). The medication guide should be given to each patient. For more information, the medication guide can be found at http://camberpharma.com/medication-guides. It is important to keep this medication and all drugs out of the reach of children. The U.S. contact number for Camber Pharmaceuticals is 1-866-495-1995. Manufactured by Annora Pharma Pvt. Ltd. in Sangareddy, Telangana, India. Manufactured for Camber Pharmaceuticals, Inc. in Piscataway, NJ.*

The text provided appears to be a table showing the mean pain score over a 8-week period. The table includes two periods: a 4-week dose titration period and a 4-week fixed dose period. The treatment options being tested are a placebo and gabapentin at a dose of 3600mg per day. The baseline pain score is not visible, but the subsequent weeks are labeled from 1 to 8.*

This text appears to be a table or graph showing the duration, dosage, and pain score for a study involving three different treatments: placebo, 1800 mg/day of gabapentin, and 2400 mg/day of gabapentin. The study seems to have been conducted over a period of several weeks, and there is a column indicating the baseline pain score. However, without the actual values or clearer context, it is difficult to provide a more detailed description.*

This text appears to be showing the proportions of responders (patients with a >50% reduction in pain score) at the endpoint of controlled Postherpetic Neuralgia (PHN) studies. The percentages range from 100% to 0% in decreasing intervals of 10%. The text also mentions "Study 1" and "Study 2" with corresponding percentages and dosages of "PBO GBP 3600," "GBP 1800," and "GBP 2400." There are also significant p-values indicated as "*p< 001" and "**p< 0.001."*